Invention Grant
- Patent Title: Remedies for pemphigus containing anti-Fas ligand antibodies
- Patent Title (中): 补救含有抗Fas配体抗体的天疱疮
-
Application No.: US13139048Application Date: 2009-12-14
-
Publication No.: US09255150B2Publication Date: 2016-02-09
- Inventor: Carlo Pincelli , Alessandra Marconi
- Applicant: Carlo Pincelli , Alessandra Marconi
- Applicant Address: IT Modena
- Assignee: PINCELL SRL
- Current Assignee: PINCELL SRL
- Current Assignee Address: IT Modena
- Agency: Millen, White, Zelano, Branigan, P.C.
- Priority: EPPCT/EP2008/010597 20081212
- International Application: PCT/EP2009/067129 WO 20091214
- International Announcement: WO2010/066914 WO 20100617
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The present invention refers to the use of FasL antagonists, e.g. of humanized antibodies directed against human Fas ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigus.
Public/Granted literature
- US20110243946A1 Remedies for pemphigus containing anti Fas ligand antibodies Public/Granted day:2011-10-06
Information query
